磷脂酰甘油通过危险相关分子模式抑制Toll样受体介导的炎症
本研究探讨磷脂酰甘油(PG)能否抑制抗菌肽作为危险相关分子模式(DAMP)激活Toll样受体(TLR)所引发的炎症。在原代角质形成细胞和巨噬细胞系中,PG抑制了重组S100A9经TLR2和TLR4诱导的炎症介质产生,并抑制下游TLR2和NF-κB活化;局部外用PG可改善银屑病小鼠模型的皮损和炎症。结果提示PG有作为银屑病治疗药物的开发可能。
要点
- PG抑制重组S100A9经TLR2和TLR4诱导的炎症介质产生。
- PG而非磷脂酰胆碱抑制S100A9引发的TLR2和NF-κB活化。
- 局部外用PG改善银屑病小鼠模型的皮损和炎症。
核心结论
- PG能够抑制DAMP诱导的TLR活化,从而减少炎症信号。
- 局部外用PG在银屑病小鼠模型中改善皮损和炎症。
- 结果提示开发PG作为银屑病治疗药物的可能性。
研究设计与样本
- 研究在原代角质形成细胞和巨噬细胞系中检测PG对重组S100A9经TLR2和TLR4诱导炎症的影响。
- 研究在银屑病小鼠模型中评估局部外用PG对皮损和炎症的作用。
主要发现
- 在原代角质形成细胞和巨噬细胞系中,PG抑制重组S100A9经TLR2和TLR4诱导的炎症介质产生。
- PG而非磷脂酰胆碱抑制S100A9引发的下游TLR2和NF-κB活化。
- 局部外用PG改善银屑病小鼠模型的皮损和炎症。
临床怎么用
- 原文结论仅提示开发PG作为银屑病治疗药物的可能性,未给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a common skin disorder characterized by hyperproliferation and aberrant differentiation of epidermal keratinocytes and inflammation. We previously showed that phosphatidylglycerol (PG) can regulate keratinocyte function and suppress skin inflammation. Based on data suggesting that PG can inhibit toll-like receptor (TLR) activation induced by microorganisms and their components, we determined whether PG can inhibit TLR activation in response to antimicrobial peptides. These peptides, which are up-regulated in psoriasis, are known to function as danger-associated molecular patterns (i.e., DAMPs) to activate TLRs and the innate immune system. Because S100A9 is elevated in psoriatic skin and in animal models of psoriasis, we selected S100A9 as a representative antimicrobial peptide DAMP. We showed that in primary keratinocytes and a macrophage cell line, PG suppressed inflammatory mediator production induced by recombinant S100A9 functioning through both TLR2 and TLR4. In addition, PG, but not phosphatidylcholine, inhibited downstream S100A9-elicited TLR2 and NF-κB activation. These results, to our knowledge previously unreported, show PG's ability to inhibit DAMP-induced TLR activation, thereby reducing inflammatory signals. In addition, topical PG ameliorated skin lesions and inflammation in a mouse model of psoriasis. Together, these results suggest the possibility of developing PG as a therapy for psoriasis.
引用
- Choudhary V, Uaratanawong R, Patel RR, et al. Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns. J Invest Dermatol. 2018. PMID: 30391260. doi:10.1016/j.jid.2018.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。